Simulation modeling approaches to answer clinically relevant questions in breast cancer low-risk populations

Randomized controlled trials (RCTs) have been considered the gold standard required to address the value of a new intervention, in terms of efficacy and safety, by comparing it with the standard of care (control), and therefore generate the highest level of evidence (1).